Thermo Fisher Scientific Inc
재무 요약
Finnhub /stock/metric · 연간 기준 · 캐시 6h▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)
관련 뉴스
Finnhub /company-news · 최근 14일 · 캐시 30minNvidia Targets a $300 Billion Pharma Market
BioNeMo Agent Toolkit launches with more than 50 adopters including Anthropic, OpenAI, Eli Lilly
원문 보기 ↗ YahooGlobal Decentralized Clinical Trials Market Size/Share Worth USD 38.3 Billion by 2035 at a 14.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Decentralized Clinical Trials Market size & share revenue was valued a…
원문 보기 ↗ YahooThermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026
WALTHAM, Mass., June 22, 2026--Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are h…
원문 보기 ↗ YahooIf You Invested $100 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 1.73% on an annualized basis producing an average annual return of 14.21%. Currently, Thermo Fisher Scientific…
원문 보기 ↗ BenzingaGlobal Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valu…
원문 보기 ↗ Yahoo3 Reasons TMO is Risky and 1 Stock to Buy Instead
Over the last six months, Thermo Fisher’s shares have sunk to $464.50, producing a disappointing 17.4% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating thei…
원문 보기 ↗ YahooGlobal Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue wa…
원문 보기 ↗ YahooAvantor (AVTR) Gets Underperform Rating From Wolfe Research
Avantor, Inc. (NYSE:AVTR) is one of the 10 Best Stocks to Buy Under $10. On June 1, Wolfe Research initiated coverage on Avantor, Inc. (NYSE:AVTR), giving the stock an Underperform rating and setting …
원문 보기 ↗ YahooPiper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with a Neutral View
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best S&P 500 Stocks to Buy Now According to Analysts. Thermo Fisher Scientific Inc. (NYSE:TMO) provides life sciences solutions, analy…
원문 보기 ↗ YahooHere's How Innovation Fuels Globus Medical's Growth Momentum
GMED is accelerating product launches, FDA clearances and R&D investment, reinforcing its strategy to expand spine and orthopedic workflows.
원문 보기 ↗ YahooThermo Fisher Tests SpheriCal Calibration As Potential Edge In Mass Spectrometry
Thermo Fisher Scientific (NYSE:TMO) has entered a Material Transfer Agreement with Polymer Factory Sweden AB. The agreement covers evaluation of Polymer Factory's SpheriCal® calibration technology in …
원문 보기 ↗ YahooPiper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with Neutral Recommendation
원문 보기 ↗ Fintel내 성향 트레이더로 도전
주어는 당신의 성향이지 이 종목이 아닙니다. 객관식 3개로 트레이더를 만들고, 6시간 동안 30분마다 가상 매매하는 걸 관전합니다. 하루 1번, 외부 개입 0.
트레이더 성향 설정
객관식만 · 주관식 0 · 생성 후 변경 불가
본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.